ArticleAmerican journal of cancer research2021

OX40 agonist combined with irreversible electroporation synergistically eradicates established tumors and drives systemic antitumor immune response in a syngeneic pancreatic cancer model.

Qi-Wei Zhang et al.PubMed ↗Full text ↗

No numbers read from the abstract.